Orchid Pharma Limited
NSE:ORCHPHARMA.NS
1490.85 (INR) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 8,193.682 | 6,658.984 | 5,595.574 | 4,500.604 | 5,080.404 | 5,999.805 | 6,829.833 | 7,882.641 | 8,725.164 | 11,644.066 | 12,984.665 | 12,278.659 | 17,923.234 | 17,817.903 | 13,434.534 | 12,968.489 | 13,009.639 | 9,638.23 | 9,366.306 | 7,223.384 |
| Cost of Revenue
| 5,873.379 | 3,846.207 | 3,262.85 | 2,399.939 | 2,671.545 | 3,111.651 | 3,731.628 | 4,173.507 | 4,302.274 | 5,239.825 | 8,341.303 | 6,552.443 | 9,086.598 | 8,688.928 | 8,395.459 | 5,856.19 | 4,793.181 | 3,536.372 | 4,089.973 | 3,331.213 |
| Gross Profit
| 2,320.303 | 2,812.777 | 2,332.724 | 2,100.665 | 2,408.859 | 2,888.154 | 3,098.205 | 3,709.134 | 4,422.89 | 6,404.241 | 4,643.362 | 5,726.216 | 8,836.636 | 9,128.975 | 5,039.075 | 7,112.299 | 8,216.458 | 6,101.858 | 5,276.333 | 3,892.171 |
| Gross Profit Ratio
| 0.283 | 0.422 | 0.417 | 0.467 | 0.474 | 0.481 | 0.454 | 0.471 | 0.507 | 0.55 | 0.358 | 0.466 | 0.493 | 0.512 | 0.375 | 0.548 | 0.632 | 0.633 | 0.563 | 0.539 |
| Reseach & Development Expenses
| 70.937 | 63.621 | 66.263 | 48.097 | 119.285 | 139.618 | 177.333 | 376.015 | 316.51 | 401.036 | 580.33 | 0 | 693.287 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 84.264 | 87.865 | 88.986 | 128.957 | 239.875 | 142.949 | 173.039 | 206.581 | 122.881 | 0 | 224.417 | 0 | 386.597 | 0 | 0 | 0 | 0 | 3,336.047 | 0 | 0 |
| Selling & Marketing Expenses
| 238.563 | 143.363 | 222.617 | 134.55 | 92.042 | 103.434 | 220.963 | 261.886 | 277.314 | 0 | 370.144 | 0 | 632.597 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1,545.934 | 231.228 | 311.603 | 263.507 | 331.917 | 246.383 | 394.002 | 468.467 | 400.195 | 1,396.826 | 2,638.269 | 0 | 1,019.194 | 0 | 0 | 0 | 0 | 3,336.047 | 0 | 0 |
| Other Expenses
| -1,237.306 | -1,128.783 | 4.895 | 4.806 | 2.249 | 18.396 | 87.511 | 147.311 | 91.566 | 0 | 0 | 0.131 | 13.892 | 6,245.809 | -2,081.976 | 5,885.963 | 5,110.803 | 847.33 | 3,747.785 | 2,956.808 |
| Operating Expenses
| 1,545.934 | 1,201.372 | 2,657.142 | 2,597.692 | 3,725.791 | 3,624.718 | 3,993.253 | 4,247.927 | 4,167.68 | 5,761.888 | 5,119.767 | 5,972.021 | 6,481.639 | 6,245.809 | -2,081.976 | 5,885.963 | 5,110.803 | 4,183.377 | 3,747.785 | 2,956.808 |
| Operating Income
| 774.369 | 289.926 | -338.899 | -504.944 | -721.75 | -736.564 | -973.544 | -5,576.34 | -3,212.589 | -47.265 | -870.16 | -245.805 | 793.176 | 2,883.166 | 7,121.051 | 1,226.336 | 3,105.655 | 1,918.481 | 1,528.548 | 935.346 |
| Operating Income Ratio
| 0.095 | 0.044 | -0.061 | -0.112 | -0.142 | -0.123 | -0.143 | -0.707 | -0.368 | -0.004 | -0.067 | -0.02 | 0.044 | 0.162 | 0.53 | 0.095 | 0.239 | 0.199 | 0.163 | 0.129 |
| Total Other Income Expenses Net
| 145.083 | 241.008 | -265.315 | -447.545 | 24.832 | 1,430.643 | -3,016.084 | -4,933.051 | -3,410.391 | -2,544.259 | -2,946.605 | -2,519.383 | -1,854.137 | -1,167.519 | -2,422.704 | -1,564.501 | -820.005 | -992.915 | -878.448 | -735.458 |
| Income Before Tax
| 919.452 | 552.469 | -568.987 | -952.489 | -1,310.701 | 694.079 | -3,989.628 | -5,385.346 | -2,963.634 | -2,591.524 | -3,816.766 | -3,026.7 | 754.362 | 1,715.647 | 4,698.347 | -338.165 | 2,285.65 | 925.566 | 650.1 | 199.888 |
| Income Before Tax Ratio
| 0.112 | 0.083 | -0.102 | -0.212 | -0.258 | 0.116 | -0.584 | -0.683 | -0.34 | -0.223 | -0.294 | -0.247 | 0.042 | 0.096 | 0.35 | -0.026 | 0.176 | 0.096 | 0.069 | 0.028 |
| Income Tax Expense
| -31.191 | 260.447 | -499.801 | 259.063 | 65.535 | -569.676 | -461.944 | -480.432 | -172.507 | 1,276.384 | 83.484 | -272.958 | -220.421 | 153.779 | 1,305.808 | 151.734 | 532.251 | 140.078 | 77.1 | 21.033 |
| Net Income
| 921.665 | 463.183 | -19.512 | -1,165.3 | -1,310.701 | 694.079 | -3,527.684 | -4,904.914 | -2,791.127 | -1,311.019 | -3,720.182 | -2,753.742 | 974.783 | 1,561.868 | 3,392.539 | -489.899 | 1,753.399 | 785.488 | 573 | 220.921 |
| Net Income Ratio
| 0.112 | 0.07 | -0.003 | -0.259 | -0.258 | 0.116 | -0.517 | -0.622 | -0.32 | -0.113 | -0.287 | -0.224 | 0.054 | 0.088 | 0.253 | -0.038 | 0.135 | 0.081 | 0.061 | 0.031 |
| EPS
| 19.06 | 11.35 | -0.48 | -28.55 | -14.75 | 7.8 | -39.65 | -55.13 | -32.07 | -3,905.89 | -11,509.89 | -39.09 | 13.84 | 22.17 | 48.16 | -7.14 | 26.93 | 11.95 | 10.27 | 4.53 |
| EPS Diluted
| 19.06 | 11.35 | -0.48 | -28.55 | -14.75 | 7.8 | -39.65 | -55.13 | -32.07 | -3,905.89 | -11,509.36 | -39.09 | 13.67 | 18.32 | 38.21 | -5.46 | 17.91 | 10.75 | 9.43 | 4.3 |
| EBITDA
| 1,106.74 | 1,030.49 | 616.248 | 630.472 | -10.787 | -6.806 | 359.585 | 957.863 | 1,899.422 | 2,116.633 | 809.326 | 1,064.259 | 4,145.864 | 4,218.208 | 8,670.047 | 2,566.261 | 4,112.439 | 2,769.374 | 2,386.724 | 1,573.193 |
| EBITDA Ratio
| 0.135 | 0.155 | 0.11 | 0.14 | -0.002 | -0.001 | 0.053 | 0.122 | 0.218 | 0.182 | 0.062 | 0.087 | 0.231 | 0.237 | 0.645 | 0.198 | 0.316 | 0.287 | 0.255 | 0.218 |